In late October, U.S. Customs and Border Protection (CBP) officers in Cincinnati, working with the U.S. Food and Drug Administration (FDA) Office of Criminal Investigation and FDA Office of Import Operations, conducted an operation to intercept high-risk ophthalmology products and misbranded prescription pharmaceuticals destined for locations across the United States.
During the operation, CBP and FDA officers seized 398 shipments containing a total of 8,521 pairs of undeclared or misdeclared contact lenses. Additionally, they confiscated 50 other shipments that included misbranded or misdeclared FDA-regulated drugs or medical devices such as GLP1 medications, Botox, dermal fillers, skin care products, and several other substances prohibited by the FDA. The combined Manufacturer’s Suggested Retail Price for these pharmaceuticals was $407,784 if they had been legally imported.
Director of Field Operations LaFonda Sutton-Burke from the Chicago Field Office stated: “Counterfeit products, such as these items, can contain toxic substances that can impact the public’s health. Counterfeiters have no moral compass and will counterfeit just about anything to make a buck. We have encountered counterfeit makeup, perfumes, toys, clothing, electronics, machinery parts – basically, anything in demand, we’ve seen it. The movement of these goods into online marketplaces pose a significant risk to the American consumer.”
The FDA reminds consumers that all contact lenses are considered medical devices requiring a valid prescription from a licensed optometrist and cannot be sold over the counter legally. If individuals suspect illegal sales of contacts or other medical products by vendors, they are encouraged to report this activity to the FDA.
Imported pharmaceuticals must comply with FDA standards for quality, safety, and effectiveness. Many online pharmacies do not meet U.S. pharmacy requirements; this can lead to health risks for consumers who may unknowingly purchase inferior or unsafe products at lower prices. Risks include unknown ingredients and unpredictable side effects.
Past joint operations between agencies have resulted in significant seizures of infringing items and provided opportunities for further enforcement actions. For example, during a similar operation in fiscal year 2025, authorities seized 146 shipments and denied entry to another 38 involving unapproved contact lenses and other regulated items.
CBP describes itself as America’s frontline law enforcement organization responsible for protecting national borders on land, air, and sea while enforcing safe travel and trade practices.
